Related Experiment Videos
[Tuberculosis following kidney transplantation]
Der Urologe. Ausg. A
|July 1, 1984
Summary
Tuberculosis (TB) affects 1% of kidney transplant recipients within a year. Early diagnosis via chest X-ray improves survival, while miliary TB poses a significant risk. Prophylactic TB therapy is advised for unexplained fever or resistant pneumonia.
Area of Science:
- Nephrology
- Infectious Diseases
- Transplantation Immunology
Context:
- Kidney transplantation recipients face risks of opportunistic infections.
- Tuberculosis (TB) is a significant concern in immunosuppressed populations.
- Post-transplant infections can lead to severe morbidity and mortality.
Purpose:
- To analyze the incidence and outcomes of tuberculosis in kidney transplant recipients.
- To identify risk factors and clinical presentations of post-transplant TB.
- To evaluate the effectiveness of diagnostic and therapeutic strategies for TB in this cohort.
Summary:
- Morbidity of tuberculosis post-kidney transplantation is approximately 1%, with all cases occurring within one year.
- A higher incidence was observed in patients from outside Central Europe.
- Early diagnosis via chest X-ray in asymptomatic patients led to survival, whereas miliary tuberculosis had a high mortality rate despite treatment.
- Prophylactic antituberculous therapy should be considered for unexplained fever or antibiotic-resistant pneumonia, even without confirmed microbiological evidence.
Impact:
- Highlights the importance of vigilant TB screening in kidney transplant recipients.
- Informs clinical decision-making regarding prophylactic treatment for suspected TB.
- Emphasizes the diagnostic value of routine chest X-rays in early TB detection.
- Underscores the critical need for prompt and appropriate management of post-transplant tuberculosis.